These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Facilitated percutaneous intervention following combination therapy with reteplase and abciximab for acute myocardial infarction. Weinstock BS J Invasive Cardiol; 2002 Feb; 14(2):100-4; quiz 104-5. PubMed ID: 11818648 [No Abstract] [Full Text] [Related]
9. Combined fibrinolysis using reduced-dose alteplase plus abciximab with immediate rescue angioplasty versus primary angioplasty with adjunct use of abciximab for the treatment of acute myocardial infarction: Asia-Pacific Acute Myocardial Infarction Trial (APAMIT) pilot study. Wong A; Mak KH; Chan C; Koh TH; Lau KW; Lim TT; Lim ST; Wong P; Sim LL; Lim YT; Tan HC; Lim YL Catheter Cardiovasc Interv; 2004 Aug; 62(4):445-52. PubMed ID: 15274152 [TBL] [Abstract][Full Text] [Related]
10. Economic analysis of the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT-3) study: costs of reperfusion strategies in acute myocardial infarction. Kaul P; Armstrong PW; Cowper PA; Eisenstein EL; Granger CB; Van de Werf F; Mark DB Am Heart J; 2005 Apr; 149(4):637-44. PubMed ID: 15990746 [TBL] [Abstract][Full Text] [Related]
11. Facilitated PCI for ST segment elevation myocardial infarction. Young JJ J Invasive Cardiol; 2004 Sep; Suppl():4-9. PubMed ID: 23573663 [No Abstract] [Full Text] [Related]
12. Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials. De Luca G; Suryapranata H; Stone GW; Antoniucci D; Tcheng JE; Neumann FJ; Bonizzoni E; Topol EJ; Chiariello M J Am Coll Cardiol; 2006 Feb; 47(3):685-6. PubMed ID: 16458158 [No Abstract] [Full Text] [Related]